Journal Finder

Cancer Treatment Communications is a new online only open access journal dedicated to publishing communications, case reports and other short form papers that report clinical research, improve clinical practice knowledge in oncology, or address the new challenges of cancer personalized medicine.Articles must be authentic, understandable, educational and clinically interesting to an international audience of medical and surgical oncologists, trainees and researchers in all oncology specialties, as well as clinicians in related fields.All articles submitted are peer reviewed and if accepted for publication, authors are notified of this decision and requested to pay an Article Processing Fee of US $600 / 458 Euro per article (exclusive of UK VAT at 20% which will be charged by Elsevier Ltd). Following payment of this fee, the article will be made open access to all on ScienceDirect and Cancer Treatment Communications.

Cancer Treatment Reviews is an international journal that helps keep both the clinician and researcher abreast of developments in cancer treatment research through the publication of state-of-the-art, authoritative reviews.Each issue provides topical reviews under the following regular sections:• Comments on controversy;• Tumor reviews;• Anti-tumor treatments;• New drugs;• Complications of treatment;• General and supportive care;• Laboratory/clinic interface.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials.

Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.

Carbohydrate Polymers covers the study and exploitation of polymers of monosaccharides which have current or potential application in areas such as bioenergy, bioplastics, biomaterials, nanotechnology, biorefining, drug delivery, food, chemistry, packaging , paper, pharmaceuticals, medicine, oil recovery, textiles and wood.The role of the well-characterized carbohydrate polymer must be the major proportion of the work reported, not peripheral. At least one named carbohydrate polymer must be cited and be the main focus of the title of the paper, and of the paper itself. Research must be innovative and advance scientific knowledge. Where a polysaccharide is obtained from a supplier, essential structural information which will affect its behavior in the subsequent work should be given. For example, molecular size/viscosity information, mannuronate/glucoronate ration for alginates, degree of esterification for pectin, degree of deacetylation for chitosan. Editors are unlikely to send papers for formal review with a statement such as "sodium alginate was purchased from XXX Inc." unless additional information is supplied. To be acceptable, the paper must include some characterization of the polysaccharide (if not already known) in addition to the application studied. Purity and monosaccharide composition are essential; some molecular size and linkage information is highly desirable.Topics include:• structure and property relationships• analytical methods• chemical, enzymatic and physical modifications• biosynthesis• natural functions• interactions with other materialsExamples of papers which are not appropriate for Carbohydrate Polymers include:• papers which focus on biological, physiological and pharmacological aspects of non-carbohydrate molecules attached to, or mixed with, carbohydrate polymers.• papers on the materials science of biocomposites where there is no mention of any specific carbohydrate polymer, or the role of the carbohydrate polymer is not the major proportion of the study.• papers focusing on polyalkanoates, polylactic acid or lignin.• routine studies of extraction yields without characterisation of the extracted polysaccharide.• routine studies of complexation of a drug with a single cyclodextrin.• applications of new polysaccharides where the structure of the polysaccharide is unknown.• Papers on the production and isolation of enzymes which act on polysaccharides (studies on the mode of action of an enzyme on a polysaccharide are within the journal scope).• Papers where the degree of polymerization of the saccharide chain is less than four.

Carbohydrate Research publishes outstanding and timely research reports on molecular aspects of carbohydrate chemistry, biochemistry, chemical biology and glycobiology.Areas of interest include:• Sugars, glycosides and their derivatives; oligo- and poly-saccharides; glycoconjugates• Chemical and enzymatic synthesis of carbohydrate-containing molecules. • Isolation and structural characterization of novel carbohydrate-containing molecules• Experimental and theoretical studies on structure, dynamics and mechanism• Analytical chemistry and biochemistry, including molecular probes• Studies of carbohydrate-processing, including enzyme action, mechanism and inhibition• Glycobiology, glycan metabolism and biosynthesis• Glycomics and glycoinformatics• Molecular aspects of glycoimmunochemistry• Molecular aspects of glyconanoparticles and carbohydrate materialsThe journal includes full-length research papers, reviews and notes, all of which are subjected to rigorous peer review prior to acceptance. Molecular-level characterization of all materials under investigation is required.It is now possible to submit your paper online and benefit from considerably shorter review and publication times. For further information please visit http://www.elsevier.com/authors

The journal Carbon is an international multidisciplinary forum for communicating scientific advances in the field of carbon materials and carbon nanomaterials. The journal reports significant new findings related to the formation, structure, properties, behaviors, and technological applications of carbons, which are a broad class of ordered or disordered solid phases composed primarily of elemental carbon. These materials can be either synthetic or of natural origin, and include, but are not limited to, graphene and graphene-oxide, carbon nanotubes, carbon fibers and filaments, graphite, porous carbons, pyrolytic carbon, glassy carbon, carbon black, diamond and diamond-like carbon, fullerenes, and chars. Papers on composites will be considered if the carbon component is a major focus of the paper's scientific content. Papers on organic substances may be considered if they are precursors for such carbon materials. Relevant application areas for carbon materials include, but are not limited to, electronic and photonic devices, structural and thermal applications, smart materials and systems, energy storage and conversion, catalysis, environmental protection, and biology and medicine.Carbon publishes comprehensive research articles, Letters to the Editor, and invited reviews by leading experts in the field. Papers will be selected that have high scientific merit, impart important new knowledge, and are of high interest to the international carbon materials community. The journal welcomes manuscripts on both bulk and nanoscale carbon materials and is particularly interested in manuscripts that help define and develop the basic science that applies to all carbons, including both established and emerging materials.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cardiac Electrophysiology Clinics provides you with practical, hands-on advice on the evaluation and management of patients with heart rhythm disorders. Each issue provides expert, state-of-the-art discussions on a single topic relevant to your practice. You'll find clear, comprehensive coverage on valuable topics such as sudden cardiac death, diagnostic evaluation of arrhythmias, advances in arrhythmia analysis, arrhythmias in special populations, antiarrhythmic drug therapy, cardiac pacing and defibrillation, genetics and pharmacogentics, and much more.Cardiac Electrophysiology Clinics is published four times a year—March, June, September, and December.

Published four times a year—in February, May, August, and November—Cardiology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Tailored to meet the needs of those in the field of cardiology, each issue focuses on a single cardiology topic, including acute coronary syndromes/cardiac emergencies, coronary artery disease, heart failure, heart rhythm disorders, and much more.

Cardiovascular Pathology is a bimonthly journal that presents articles on topics covering the entire spectrum of cardiovascular disease. The Journal's primary objective is to publish papers on disease-oriented morphology and pathogenesis from clinicians and scientists in the cardiovascular field. Subjects covered include cardiovascular biology, prosthetic devices, molecular biology and experimental models of cardiovascular disease.Cardiovascular Pathology also publishes timely and informative reviews on scientific areas in cardiovascular pathology as well as case reports that represent significant or unique observations.For more information about the Society for Cardiovascular Pathology (SCVP), please visit their website at URL: http://scvp.net .Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine.Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management; and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, congenital heart disease, coronary heart disease, epidemiology, genetics, health services and outcomes research, invasive imaging, molecular cardiology, preventive cardiology, and vascular medicine.Cardiovascular Revascularization Medicine will consider all articles describing clinical trials and translational research (ie, those that unite the clinic with the laboratory). The Journal publishes original articles, rapid communications, reviews, technical notes, teaching editorials, and special features. Original articles that address any aspect of cardiovascular revascularization medicine are invited. Letters to the Editor and interesting images are encouraged.